SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-24-000161
Filing Date
2024-07-03
Accepted
2024-07-03 14:47:16
Documents
1
Period of Report
2024-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 7366
  Complete submission text file 0000874015-24-000161.txt   8912
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ASPREVA PHARMACEUTICALS CORPORATION 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8
Business Address
Hayden Michael R (Reporting) CIK: 0001352908 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 241099651